60 Degrees Pharmaceuticals Inc. Insider Trading

SXTP

⊜ Compare

Last 12 months

Insiders bought 30K on the open market and sold nothing.

Net open-market

+30K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Jun 2026

Jun 12, 2026

Get an email when SXTP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 12	Geoffrey S Dow President and CEO	Bought	7,350	$1.38	10K	44%	Form 4
Dec 15, 2025	Geoffrey S Dow President and CEO	Bought	9,670	$0.80	8K	19%	Form 4
Dec 10, 2025 – Dec 11, 2025	Geoffrey S Dow President and CEO	Bought 2 parts	12,963	$0.94 average	12K	35%	Form 4
Jun 3, 2025	Cheryl Xu Director	Bought 2 parts	5,000	$2.88 average	14K	46%	Form 4
Dec 12, 2024 – Dec 16, 2024	Cheryl Xu Director	Bought 7 parts	13,000	$1.65 average	21K	32%	Form 4
Dec 5, 2024 – Dec 9, 2024	Geoffrey S Dow President and CEO	Bought 3 parts	73,951	$1.21 average	90K	97%	Form 4
Nov 19, 2024 – Nov 21, 2024	Geoffrey S Dow President and CEO	Bought 3 parts	7,000	$0.91 average	6K	10%	Form 4

Jun 12
Geoffrey S Dow
President and CEO · bought 7,350 at $1.38
10K
44% of stake
Dec 15, 2025
Geoffrey S Dow
President and CEO · bought 9,670 at $0.80
8K
19% of stake
Dec 10, 2025 – Dec 11, 2025
Geoffrey S Dow
President and CEO · bought 12,963 at avg $0.94
12K
35% of stake
Jun 3, 2025
Cheryl Xu
Director · bought 5,000 at avg $2.88
14K
46% of stake
Dec 12, 2024 – Dec 16, 2024
Cheryl Xu
Director · bought 13,000 at avg $1.65
21K
32% of stake
Dec 5, 2024 – Dec 9, 2024
Geoffrey S Dow
President and CEO · bought 73,951 at avg $1.21
90K
97% of stake
Nov 19, 2024 – Nov 21, 2024
Geoffrey S Dow
President and CEO · bought 7,000 at avg $0.91
6K
10% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SXTP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SXTP

CompareIntrinsic value

IGCIGC Pharma Inc.

$0.20+5.26%26

NEUPNeuphoria Therapeutics Inc.

$2.98-0.33%10

ORGSOrgenesis Inc.

$0.05+0.00%20

LGVNLongeveron Inc.

$1.78+0.00%10

STTKShattuck Labs Inc.

$5.29-3.38%40

RFLRafael Holdings Inc.

$1.07-0.93%40

DAREDare Bioscience Inc.

$0.66+1.83%10

SCNXScienture Holdings Inc.

$3.42-0.87%0

Spot a number that looks wrong? Check it in SXTP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SXTP

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.